Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "hyaluronic acid receptor" refers to a group of cell surface proteins that specifically bind hyaluronic acid (HA). These receptors mediate diverse biological processes, including cell adhesion, migration, proliferation, inflammation, tissue repair, and tumor progression. Major HA receptors include CD44, RHAMM, LYVE-1, HARE/Stabilin-2, Layilin, and TLR4. Binding of HA to these receptors initiates intracellular signaling cascades affecting gene expression and cellular behavior. Alterations in HA receptor expression or function are associated with various diseases, including cancer and inflammatory disorders.
HA binding initiates intracellular signaling cascades affecting gene expression related to inflammation response, cytoskeletal rearrangement/motility, survival/apoptosis pathways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hyaluronic Acid Receptor (HA Receptor).